| Picato |
Human |
ingenol mebutate |
Ingenol mebutate |
EMEA/H/C/002275 |
LEO Laboratories Ltd. |
2012/11/15
|
Withdrawn |
| Forxiga |
Human |
dapagliflozin |
dapagliflozin propanediol monohydrate |
EMEA/H/C/002322 |
AstraZeneca AB |
2012/11/11
|
Authorised |
| Adcetris |
Human |
brentuximab vedotin |
Brentuximab vedotin |
EMEA/H/C/002455 |
Takeda Pharma A/S |
2012/10/25
|
Authorised |
| Glybera |
Human |
alipogene tiparvovec |
alipogene tiparvovec |
EMEA/H/C/002145 |
uniQure biopharma B.V. |
2012/10/25
|
Expired |
| Xalkori |
Human |
crizotinib |
crizotinib |
EMEA/H/C/002489 |
Pfizer Europe MA EEIG |
2012/10/23
|
Authorised |
| Enurev Breezhaler |
Human |
glycopyrronium bromide |
glycopyrronium bromide |
EMEA/H/C/002691 |
Novartis Europharm Ltd |
2012/09/28
|
Authorised |
| Tovanor Breezhaler |
Human |
glycopyrronium bromide |
glycopyrronium bromide |
EMEA/H/C/002690 |
Novartis Europharm Limited |
2012/09/28
|
Authorised |
| Seebri Breezhaler |
Human |
glycopyrronium bromide |
glycopyrronium bromide |
EMEA/H/C/002430 |
Novartis Europharm Limited |
2012/09/28
|
Authorised |
| Dacogen |
Human |
decitabine |
decitabine |
EMEA/H/C/002221 |
Janssen-Cilag International N.V. |
2012/09/20
|
Authorised |
| Inlyta |
Human |
axitinib |
axitinib |
EMEA/H/C/002406 |
Pfizer Europe MA EEIG |
2012/09/03
|
Authorised |
| NovoThirteen |
Human |
catridecacog |
catridecacog |
EMEA/H/C/002284 |
Novo Nordisk A/S |
2012/09/03
|
Authorised |
| Revestive |
Human |
teduglutide |
teduglutide |
EMEA/H/C/002345 |
Takeda Pharmaceuticals International AG Ireland |
2012/08/30
|
Authorised |
| Zoledronic acid Mylan |
Human |
zoledronic acid |
zoledronic acid |
EMEA/H/C/002482 |
Mylan Pharmaceuticals Limited |
2012/08/23
|
Authorised |
| Jakavi |
Human |
ruxolitinib |
ruxolitinib phosphate |
EMEA/H/C/002464 |
Novartis Europharm Limited |
2012/08/23
|
Authorised |
| Zyclara |
Human |
imiquimod |
imiquimod |
EMEA/H/C/002387 |
Viatris Healthcare Limited |
2012/08/23
|
Authorised |
| Cuprymina |
Human |
copper (64Cu) chloride |
copper (64Cu) chloride |
EMEA/H/C/002136 |
A.C.O.M. - Advanced Center Oncology |
2012/08/23
|
Authorised |
| Zinforo |
Human |
ceftaroline fosamil |
ceftaroline fosamil |
EMEA/H/C/002252 |
Pfizer Ireland Pharmaceuticals |
2012/08/22
|
Authorised |
| Zoledronic acid Teva |
Human |
zoledronic acid |
zoledronic acid |
EMEA/H/C/002439 |
Teva B.V. |
2012/08/16
|
Authorised |
| Zoledronic acid Teva Pharma |
Human |
zoledronic acid |
zoledronic acid |
EMEA/H/C/002437 |
Teva B.V. |
2012/08/15
|
Withdrawn |
| Zoledronic acid medac |
Human |
zoledronic acid |
zoledronic acid monohydrate |
EMEA/H/C/002359 |
medac Gesellschaft für klinische Spezialpräparate mbH |
2012/08/03
|
Authorised |